Patients not just at the table, but creating their own: In conversation with Donna Cryer
Artificial intelligence is now embedded in every stage of drug development, but the patients whose lives depend on those decisions are almost entirely absent from the design, governance, and oversight of these systems.
In a new pharmaphorum podcast, Nicole Raleigh speaks with Donna Cryer, founding partner and Chief Patient Officer of CryerHealth, LLC, as well as patient advocate, FDA Patient Representative, and founder of the Global Liver Institute and member of the Board of Advisors at PathAI.
Cryer discusses why patient inclusion is not the same as patient leadership, and why that distinction matters for drug development and AI governance.
You can listen to episode 285 of the pharmaphorum podcast in the player below, download the episode to your computer, or find it – and subscribe to the rest of the series – on Apple Podcasts, Spotify, Overcast, Pocket Casts, Podbean, and pretty much wherever else you download your other podcasts from.
